SCHEMBL6015146

SCHEMBL6015146

CCc1ccc(C=O)cc1Cl

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.59
ALDH1A3 P47895 6/20 0.54
ALDH3A1 P30838 4/20 0.54
PTGER4 P35408 1/20 0.44
HSD17B10 Q99714 2/20 0.43
VCAM1 P19320 1/20 0.43
CYP1A2 P05177 1/20 0.42
TACR2 P21452 1/20 0.40
TSHR P16473 1/20 0.39
NR3C1 P04150 1/20 0.39
PGR P06401 1/20 0.39
NR3C2 P08235 1/20 0.39
TYR P14679 1/20 0.39
KDM4E B2RXH2 1/20 0.39
PTGS2 P35354 1/20 0.39
RAB9A P51151 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
CYP2A6 P11509 1/20 0.38
FDPS P14324 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27848038 0.86 ALDH1A3 (0.54) ALDH1A1ALDH1A3ALDH3A1PTGER4HSD17B10
SCHEMBL27687432 0.83 ALDH1A3 (0.51) ALDH1A1ALDH1A3ALDH3A1PTGER4HSD17B10
SCHEMBL670230 0.83 ALDH1A1 (0.59) ALDH1A1ALDH1A3ALDH3A1PTGER4HSD17B10
SCHEMBL3657410 0.82 ALDH1A1 (0.57) ALDH1A1ALDH1A3ALDH3A1PTGER4HSD17B10
SCHEMBL16961426 0.82 ALDH1A1 (0.39) ALDH1A1ALDH1A3ALDH3A1CYP1A2TDP1
SCHEMBL14321571 0.82 ALDH1A1 (0.57) ALDH1A1ALDH1A3ALDH3A1PTGER4HSD17B10
SCHEMBL16953512 0.82 ALDH3A1 (0.38) ALDH1A1ALDH1A3ALDH3A1
Ethane SCHEMBL2154475 0.82 ALDH1A1 (0.57) ALDH1A1ALDH1A3ALDH3A1PTGER4HSD17B10
SCHEMBL6299303 0.82 ALDH1A1 (0.57) ALDH1A1ALDH1A3ALDH3A1PTGER4HSD17B10
SCHEMBL13269290 0.81 ALDH1A1 (0.52) ALDH1A1ALDH1A3ALDH3A1PTGER4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6984740-B2 Symmetrical halogenated and alkylated alditol derivatives and compositions and articles containing same MILLIKEN & COMPANY (US) 2006-01-10 US disclosed
EP-1425342-A4 NOVEL SYMMETRICAL SUBSTITUTED BENZALDEHYDE ALDITOL DERIVATIVES AND COMPOSITIONS AND ARTICLES CONTAINING SAME MILLIKEN & CO (US) 2005-01-05 EP disclosed
CN-1514851-A Novel symmetrical substituted benzaldehyde alditol derivatives and compositions and articles containing same 美利肯公司 2004-07-21 CN disclosed
EP-1425342-A2 NOVEL SYMMETRICAL SUBSTITUTED BENZALDEHYDE ALDITOL DERIVATIVES AND COMPOSITIONS AND ARTICLES CONTAINING SAME Milliken & Company (US) 2004-06-09 EP disclosed
US-20030127631-A1 Novel symmetrical halogenated and alkylated alditol derivatives and compositions and articles containing same ANDERSON JOHN D (US) 2003-07-10 US disclosed
US-6547988-B2 Plastic additives which are useful as nucleating agents and which are especially useful for improving the optical properties of polymeric materials; also useful as gelling agents for water and organic solvents MILLIKEN & COMPANY 2003-04-15 US disclosed
US-20030008951-A1 Novel symmetrical halogenated and alkylated alditol derivatives and compositions and articles containing same MILLIKEN & COMPANY 2003-01-09 US disclosed
WO-2002077086-A2 NOVEL SYMMETRICAL SUBSTITUTED BENZALDEHYDE ALDITOL DERIVATIVES AND COMPOSITIONS AND ARTICLES CONTAINING SAME MILLIKEN & COMPANY (US) 2002-10-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030008951-A1 Novel symmetrical halogenated and alkylated alditol derivatives and compositions and articles containing same ADH1C, ADH1A, ALDOA ALDH1A1 69/4885ALDH1A3 55/4885ALDH3A1 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.